1198744-87-4

Upstream product

• 1030828-84-2 3-(4-chlorophenyl)-2-propionic acid ethyl ester 
• 1030829-56-1 ethyl 3-[4-(benzyloxy)phenyl]prop-2-ynoate 
• 1030829-42-5 4-methyl-2-((1-methylethyl)oxy)pyridine 
• 1030828-97-7 5-[4-(benzyloxy)phenyl]-3-(methoxymethoxy)-1,2-oxazole 
• 1030828-96-6 5-[4-(benzyloxy)phenyl]-1,2-oxazol-3-ol 
• 1030828-94-4 4-[3-(methoxymethoxy)-1,2-oxazol-5-yl]phenol 
• 1198744-86-3 1-(2-((1-methylethyl)oxy)pyridine-4-yl)propan-2-ol 
• 13466-41-6 4-methyl-1H-pyridin-2-one 
• 540-38-5 p-Iodophenol 

Downstream Products

• 1198744-88-5 2-((1-methylethyl)oxy)-4-((2S)-2-((4-(3-(((methyloxy)methyl)oxy)isoxazol-5-yl)phenyl)oxy)propyl)pyridine 
• 1198744-89-6 2-((1-methylethyl)oxy)-4-((2R)-2-((4-(3-(((methyloxy)methyl)oxy)isoxazol-5-yl)phenyl)oxy)propyl)pyridine 
• 1198744-80-7 5-(4-(((1S)-1-methyl-2-(2-((1-methylethyl)oxy)pyridin-4-yl)ethyl)oxy)phenyl)isoxazol-3-ol sodium salt 

Relevant academic research and scientific papers

NOVEL ISOXAZOLE DRIVATIVE

Disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an agonistic activity on GPR120 and is therefore useful for the treatment of diabetes, obesity or hyperlipemia. [In formula (I), the A represents a phenyl group which may be substituted by a lower alkoxy group or the like; the 13 represents a bivalent group produced by removing two hydrogen atoms from a benzene ring which may be substituted by a halogen atom or the like; X represents a lower alkylene group having 2 to 4 carbon atoms in its main chain or the like, wherein a carbon atom constituting the main chain may be substituted by an oxygen atom or the like; and Y represents a hydrogen atom or the like.]